Tag Archives: TLR3 agonist
Efficacy of rintatolimod (Ampligen) in CFS/ME
Review abstract: Chronic fatigue syndrome/ Myalgic encephalomyelitis (CFS/ME) is a poorly understood seriously debilitating disorder in which disabling fatigue is an universal symptom in combination with a variety of variable symptoms. The only drug in advanced clinical development is rintatolimod, … Continue reading
Posted in News
Tagged ampligen, dsRNA, Rintatolimod, TLR3 agonist, Toll-Like Receptor 3 agonist, WM Mitchell
Comments Off on Efficacy of rintatolimod (Ampligen) in CFS/ME
